ANGO - CONSENSUS CO - AngioDynamics, Inc.

This price chart serves as an indicator for AngioDynamics, Inc. (ANGO), which combines minimally invasive oncology solutions with a radical product line update through the launch of thrombectomy systems. The current metric is 20.09. AngioDynamics, Inc. (ANGO) generates revenue from the supply of radiofrequency ablation and vascular therapy equipment, targeting the global market of specialized clinics and surgeons.

To find a balance between cost and business quality, use the arithmetic mean of target prices from investment houses, which reflects market expectations for the asset's fair value. In the case of AngioDynamics, Inc. (ANGO), the consolidated target valuation from investment banks allows for tracking analyst reactions to device portfolio optimization and debt reduction, signaling the start of a trend recovery.